×
About 10,518 results

Financial Toxicity Is a Common Complication of Gynecologic Cancers
https://emedicine.medscape.com/viewarticle/928014

More than one-fifth of patients being treated for gynecologic malignancies experience financial toxicity, results of a single-center study suggest. Among 5,188 patients treated for gynecologic cancers, 1,155 (22%) experienced financial toxicity, measured by bills sent to collection, financial assistance, bankruptcy, or similar measures, reported Emeline Aviki, MD, of Memorial Sloan Kettering Ca...

Colorectal Cancer: Proposed Treatment Guidelines for the COVID-19 Era
https://emedicine.medscape.com/viewarticle/928133

In light of the rapid changes affecting cancer clinics due to the COVID-19 pandemic, Drs David Kerr and Rachel Kerr, both specialists in gastrointestinal cancers at the University of Oxford in Oxford, United Kingdom, drafted these guidelines for the use of chemotherapy in colorectal cancer patients. Drs Kerr and Kerr are putting forth this guidance as a topic for discussion and debate, and Meds...

'Brutal' Plan to Restrict Palliative Radiation During Pandemic
https://emedicine.medscape.com/viewarticle/928185

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. A major comprehensive cancer center at the epicenter of the New York City COVID-19 storm is preparing to scale back palliative radiation therapy (RT), anticipating to focus on only oncologic emergencies. "We're not there yet, but we're anticipating when the time comes in the next few weeks that ...

COVID-19 Diary Day 2: Insomnia -- The Mark of Medical Practice
https://emedicine.medscape.com/viewarticle/928195

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. I've never been a deep sleeper, typically waking at 4 or 5 in the morning. I usually get up gradually, lingering in bed for a few minutes, checking what's happened on Twitter, and then moving things along. That's all changed. Don S. Dizon, MD These days, I bolt upright at 5 AM, heart racing, eye...

Benefits of a Brief Psychological Intervention Targeting Fear of Cancer Recurrence in People at High Risk of Developing Another Melanoma
https://emedicine.medscape.com/viewarticle/928324

Abstract and Introduction Abstract Background: People with melanoma want and need effective interventions for living with fear of cancer recurrence (FCR). Objectives: This study reports the 12-month outcomes of a brief, psychological intervention designed to reduce FCR in people at high risk of developing another primary melanoma compared with usual care. Methods: In this two-arm randomized con...

Oesophageal and Proximal Gastric Adenocarcinomas Are Rare After Detection of Helicobacter pylori Infection
https://emedicine.medscape.com/viewarticle/928320

Abstract and Introduction Abstract Background: Helicobacter pylori infection is the most important risk factor for non-proximal gastric adenocarcinoma, yet some posit it is protective against oesophageal adenocarcinoma and proximal gastric cancers. Aims: To evaluate the incidence of and risk factors for future oesophageal and proximal gastric cancers, utilizing the largest North American cohort...

Guidelines for Radiotherapy in Prostate Cancer During the Pandemic
https://emedicine.medscape.com/viewarticle/928338

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. A team of radiation oncologists has devised recommendations and a framework for managing radiotherapy in prostate cancer patients during the COVID-19 pandemic. The framework involves using remote visits via telemedicine, avoiding radiotherapy in applicable cases, deferring radiotherapy as approp...

Weight Loss Intervention Fails in Endometrial Cancer Survivors
https://emedicine.medscape.com/viewarticle/928339

Almost half of obese endometrial cancer survivors in a recent study gained weight during 12 months of follow-up, whether or not they participated in a behavioral weight loss intervention. Of 358 endometrial cancer survivors with a body mass index of at least 30 kg/m2 who were approached for participation in the randomized ScaleDown trial, 80 participated and 278 declined. The results of that st...

Differences in How Men and Women Respond to Radiotherapy?
https://emedicine.medscape.com/viewarticle/928340

Men and women who undergo treatment for cancer react differently to radiotherapy (RT), according to evidence drawn from a literature review. The study found a small but significant difference in response to RT. Women generally derive a greater survival benefit and are more likely than men to be cured, but the side effects that they suffer are more severe, say the authors. However, a radiation o...

Water-Only Fasting May Reduce Chemo Modifications, Hospital Admissions
https://emedicine.medscape.com/viewarticle/928343

Patients with gynecologic malignancies who consumed only water for 24 hours before and 24 hours after each chemotherapy cycle had fewer dose delays and reductions compared with patients who didn't fast, results of a small study showed. The study included 23 women with ovarian, uterine, or cervical cancer, most of whom received platinum-based chemotherapy and taxanes. Fewer treatment modificatio...

Childhood IBD Tied to Higher Cancer Risk Later
https://emedicine.medscape.com/viewarticle/928364

NEW YORK (Reuters Health) - Children with inflammatory bowel disease (IBD), and in particular Crohn's disease (CD), are at an elevated risk of developing cancer in adulthood, according to researchers in Canada. As Dr. Wael El-Matary of the University of Manitoba, in Winnipeg, told Reuters Health by email, "Our study showed children diagnosed with IBD have a twofold increase in the chance of dev...

Encorafenib Now Approved for BRAF-Positive Colorectal Cancer
https://emedicine.medscape.com/viewarticle/928414

The targeted agent encorafenib (Braftovi, Array BioPharma, now part of Pfizer) has been approved by the US Food and Drug Administration (FDA) for use in BRAF-positive colorectal cancer (CRC) and offers a subgroup of patients with CRC a chemotherapy-free treatment option. Encorafenib is already approved for use in BRAF-positive metastatic melanoma. The new approval is for the use of encorafenib ...

COVID-19 Diary Day 4: Am I Losing My Humanity? Already?
https://emedicine.medscape.com/viewarticle/928403

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. What a difference a week makes. Four days ago I wrote about the surge that we were expecting and how our institution was preparing by restricting visitors. Still, I was able to bend the rules and get an anxious father into the clinic so he could hear his only daughter's cancer prognosis and the ...

COVID-19: My Social Media Journey Over Cancer Delays
https://emedicine.medscape.com/viewarticle/928431

This transcript has been edited for clarity. Hello, it's Professor Karol Sikora here, talking not about cancer as usual on Medscape, but about my Twitter account. It is related. About 3 weeks ago, it was clear that policies about COVID-19 as the infection rate surged in Britain, meant that cancer patients and cardiac patients were being put off, they were being pushed aside. And of course with ...

COVID-19 Diary Day 5: Facing Deployment
https://emedicine.medscape.com/viewarticle/928432

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Bolted awake at 5 AM again today with the same sense of panic, followed by the mantra I've been using all week to calm down: "I'm home, everyone's safe." Thankfully, there are no urgent alerts in my email. The residents are still with us on the inpatient hematology-oncology ward, and no faculty ...

Treating Rectal Cancer in the COVID-19 Era: Expert Guidance
https://emedicine.medscape.com/viewarticle/928437

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. As the COVID-19 pandemic continues, minimizing risks of infection to patients with cancer while maintaining good outcomes remains a priority. An international panel of experts has now issued recommendations for treating patients with rectal cancer, which includes using a short pre-operative cour...

NCCN Panel: Defer Nonurgent Skin Cancer Care During Pandemic
https://emedicine.medscape.com/viewarticle/928440

Amid the COVID-19 pandemic, defer therapeutic lymphadenectomy for stage III melanoma and opt instead for treatment with checkpoint or BRAF/MEK inhibitors, except when metastatic nodes are threatening vital structures or neoadjuvant therapy is not possible or has already failed, the National Comprehensive Cancer Network said in a new document about managing melanoma during the pandemic. "The NCC...

Home-Based Chemo Skyrockets at One US Center
https://emedicine.medscape.com/viewarticle/928505

In the fall of 2019, the University of Pennsylvania in Philadelphia started planning a pilot program of home-based chemotherapy for two treatment regimens (one via infusion and one via injection). Six months later, the Cancer Care at Home program had referred 40 patients. The uptake within the university's large regional health system was acceptable but not rapid, admitted Amy Laughlin, MD, a h...

COVID-19 Diary Day 6: Clinicians' Choices Shouldn't Be Judged
https://emedicine.medscape.com/viewarticle/928529

Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Yesterday we celebrated the 12th birthday of my twins. We had a special dinner before we sang "Happy Birthday," ate cake (which I made myself!), and opened presents. There were no other family and friends at our house because of COVID-19. The absence of one particular woman was painfully obvious. My mother-in-...

Cancer Prevalence Among COVID-19 Patients May Be Higher Than Previously Reported
https://emedicine.medscape.com/viewarticle/928628

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. An early report pegged the prevalence of cancer among COVID-19 patients at 1%, but authors of a recent meta-analysis found an overall prevalence of 2% and up to 3% depending on the subset of data they reviewed. However, those findings are limited by the retrospective nature of the studies publis...